$60,000 of INVIVYD INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Onshoring, Domestic manufacturing Monoclonal Antibodies, Infectious diseases"
You can find more data on corporate lobbying on Quiver Quantitative.
IVVD Insider Trading Activity
IVVD insiders have traded $IVVD stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $IVVD stock by insiders over the last 6 months:
- JILL ANDERSEN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 67,962 shares for an estimated $52,780.
- WILLIAM E. DUKE (Chief Financial Officer) has made 0 purchases and 2 sales selling 40,780 shares for an estimated $31,670.
- JULIE GREEN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 40,780 shares for an estimated $31,670.
- TIMOTHY EDWARD LEE (Chief Commercial Officer) has made 0 purchases and 2 sales selling 40,780 shares for an estimated $31,670.
- ROBERT D. III ALLEN (Chief Scientific Officer) has made 0 purchases and 2 sales selling 37,722 shares for an estimated $29,295.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
IVVD Hedge Fund Activity
We have seen 64 institutional investors add shares of IVVD stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 11,853,095 shares (+276.8%) to their portfolio in Q2 2026, for an estimated $10,340,640
- EVENTIDE ASSET MANAGEMENT, LLC removed 9,071,995 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,914,408
- BVF INC/IL added 8,640,000 shares (+44.3%) to their portfolio in Q2 2026, for an estimated $7,537,536
- POINT72 ASSET MANAGEMENT, L.P. added 7,498,130 shares (+17068.0%) to their portfolio in Q2 2026, for an estimated $6,541,368
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 3,630,351 shares (-43.0%) from their portfolio in Q2 2026, for an estimated $3,167,118
- BALYASNY ASSET MANAGEMENT L.P. removed 3,515,644 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $3,067,047
- GEODE CAPITAL MANAGEMENT, LLC added 2,949,847 shares (+119.5%) to their portfolio in Q2 2026, for an estimated $2,573,446
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
IVVD Price Targets
Multiple analysts have issued price targets for $IVVD recently. We have seen 2 analysts offer price targets for $IVVD in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $10.0 on 07/07/2026
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $10.0 on 06/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
